CARE Ratings Limited — Important, 30-01-2025: Financial Result Updates

**Consolidated Financial Summary for CARE Ratings Limited**

CARE Ratings reported a substantial recovery in revenue, achieving ₹9,637.87 Cr for the quarter ended December 31, 2024, up 22.4% year-over-year from ₹7,867.67 Cr. This growth can be attributed to increased demand for rating services, market expansion initiatives, and improved operational efficiencies.

The net profit post-tax rose to ₹2,836.86 Cr, reflecting a notable increase of 18.5% compared to ₹2,392.40 Cr during the same quarter in the previous year. Earnings Per Share (EPS) stood at ₹9.30, indicating solid profitability driven by effective cost management and stable revenue streams.

Operational costs surged to ₹6,950.84 Cr, up by 18.9% year-over-year, primarily due to increased employee benefits expenses and other operational requirements as the company expands its footprint. The company’s ability to manage these costs will be crucial for maintaining profitability.

The balance sheet remains robust, with total assets of ₹91,247.85 Cr against total liabilities of ₹14,249.13 Cr, highlighting a healthy financial position that supports future growth opportunities.

Given the current financial performance and strategic outlook, particularly in terms of expense management and market positioning, investors may consider a *buy* position in CARE Ratings, capitalizing on its growth trajectory and operational improvements.